Your browser doesn't support javascript.
loading
SAPHO syndrome: the supposed trigger by isotretinoin, the efficacy of adalimumab and the specter of depressive disorder: a case report.
Luzzati, Michele; Simonini, Gabriele; Filippeschi, Cesare; Giani, Teresa; Trapani, Sandra.
Afiliación
  • Luzzati M; Post-Graduate School of Pediatrics, University of Florence, Florence, Italy. michele.luzzati@unifi.it.
  • Simonini G; Department of NEUROFARBA, University of Florence, Florence, Italy.
  • Filippeschi C; Rheumatology Department, Meyer Children's University Hospital, Florence, Italy.
  • Giani T; Dermatology Department, Meyer Children's University Hospital, Florence, Italy.
  • Trapani S; Rheumatology Department, Meyer Children's University Hospital, Florence, Italy.
Ital J Pediatr ; 46(1): 169, 2020 Nov 13.
Article en En | MEDLINE | ID: mdl-33187546

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Isotretinoína / Síndrome de Hiperostosis Adquirido / Trastorno Depresivo / Adalimumab / Antiinflamatorios Tipo de estudio: Clinical_trials Límite: Adolescent / Humans / Male Idioma: En Revista: Ital J Pediatr Asunto de la revista: PEDIATRIA Año: 2020 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Isotretinoína / Síndrome de Hiperostosis Adquirido / Trastorno Depresivo / Adalimumab / Antiinflamatorios Tipo de estudio: Clinical_trials Límite: Adolescent / Humans / Male Idioma: En Revista: Ital J Pediatr Asunto de la revista: PEDIATRIA Año: 2020 Tipo del documento: Article País de afiliación: Italia